Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Ampronix
KOREA E & EX

Medtronic Buys Tyrx Antibacterial Envelope Manufacturer

By HospiMedica International staff writers
Posted on 13 Jan 2014
Startup company Tyrx (Monmouth Junction, NJ, USA), which manufactures bioresorbable envelopes for implanted medical devices, is now a part of Medtronic (Minneapolis, MN, USA), the world's largest medical device company.

The acquisition supports Medtronic's expansion of its medical device product offerings to include broader healthcare services and solutions, providing meaningful clinical outcomes and economic value for hospitals, physicians, patients, and payers. TYRX brings to Medtronic the AIGISRx R fully resorbable antibacterial envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs), and the AIGISRx N antibacterial envelope, used with spinal cord neurostimulators.

The bioresorbable envelopes use a combination of two antibiotic drugs: Minocycline and Rifampin. Minocycline is a tetracycline-class antibiotic commonly used to treat skin acne, among other things; Rifampin is commonly used to treat tuberculosis. Both drugs have different modes of action, and working together target roughly 80% of the germs, which can be introduced during surgery, including Methicillin Resistant Staphylococcus aureus (MRSA) and a number of other pathogens.

“While the risk of infection from an implanted pacemaker or defibrillator is low for most patients, repeated operative procedures after the initial device implant are associated with a substantial incremental risk of infection. This is estimated to cost the US healthcare system more than one billion dollars per year,” said Pat Mackin, president of the cardiac rhythm disease management business and senior vice president at Medtronic. “TYRX has developed an innovative, proven technology to reduce infection risk, making the procedure safer for patients and removing significant costs from the healthcare system.”

“We look forward to joining Medtronic as part of a combined portfolio that can positively impact outcomes for patients by reducing implant-related infections, and bring value to our customers,” said Robert White, president and CEO of Tyrx.

The all-cash transaction includes an initial payment of USD 160 million plus potential earn out and performance based milestone payments.

Related Links:

Tyrx
Medtronic
Antibacterial Envelope Protects Cardiac Implants




Inditherm
JD Honigberg International
Harloff

Channels

Critical Care

view channel

Little Evidence Supports Opioid Use for Chronic Pain

A new study reveals that there is paltry evidence for the long-term safety and efficacy of opioids in the treatment of chronic pain. Researchers at the Oregon Health & Science University (OHSU; Portland, USA) and the University of Washington (Seattle, USA) searched MEDLINE, the Cochrane Central Register of Controlled... Read more

Surgical Techniques

view channel

Epidural Steroid Injections Could Help Avoid Surgery

For patients with lower back pain, epidural steroid injections (ESI) could reduce the need for surgery, according to a new study. Researchers at Massachusetts General Hospital (Boston, USA) conducted a systematic review and meta-analysis of studies to determine whether ESI could have a surgery-sparing effect in patients... Read more

Women's Health

view channel

Pregnant Women in Austria Experience Iodine Deficiency

A new study suggests that pregnant women in Austria have a potentially clinically significant iodine deficiency which could impair embryonic brain development. Researchers at the Medical University of Vienna (Austria) conducted a cross-sectional investigation of urinary iodine excretion in 246 pregnant women (2 in the... Read more

Health IT

view channel

Computer Model Predicts Public Response to Disease Outbreaks

A new computer model could help public health officials anticipate public reactions to disease outbreaks, based on a combination of data collected from hospitals, social media, and other sources. Researchers at MIT (Cambridge, MA, USA), the Draper Laboratory (Cambridge, MA, USA), and Ascel Bio (Larchmont, NY, USA),... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.